i-SENS, Inc. (099190.KQ) has a MoatMap StockRank of 19/100 based on Quality (40/100), Value (29/100), and Momentum (35/100) factor scores. The current signal is STRONG SELL.
i-SENS produces advanced medical diagnostic devices, specializing in blood glucose monitoring systems. It maintains a global competitive moat through high-precision biosensor R&D and strong growth in both the professional and consumer digital health markets.
| Price | $10.84 |
| Market Cap | $304M |
| Price/Book | 1.44 |
| Return on Equity | -1.6% |
| Return on Invested Capital | -0.8% |
| Debt/Equity | 55.13 |
| Gross Margin | 39.7% |
| Operating Margin | 2.5% |
| Free Cash Flow | $-4K |